Use of Heart Rate Reserve and Rating of Perceived Exertion to Prescribe Exercise Intensity in Diabetic Autonomic Neueropathy by Colberg, Sheri R. et al.
Old Dominion University
ODU Digital Commons
Human Movement Sciences Faculty Publications Human Movement Sciences
2003
Use of Heart Rate Reserve and Rating of Perceived
Exertion to Prescribe Exercise Intensity in Diabetic
Autonomic Neueropathy
Sheri R. Colberg
Old Dominion University, scolberg@odu.edu
David P. Swain
Old Dominion University, dswain@odu.edu
Aaron I. Vinik
Follow this and additional works at: https://digitalcommons.odu.edu/hms_fac_pubs
Part of the Endocrinology, Diabetes, and Metabolism Commons, and the Exercise Science
Commons
This Article is brought to you for free and open access by the Human Movement Sciences at ODU Digital Commons. It has been accepted for inclusion
in Human Movement Sciences Faculty Publications by an authorized administrator of ODU Digital Commons. For more information, please contact
digitalcommons@odu.edu.
Repository Citation
Colberg, Sheri R.; Swain, David P.; and Vinik, Aaron I., "Use of Heart Rate Reserve and Rating of Perceived Exertion to Prescribe
Exercise Intensity in Diabetic Autonomic Neueropathy" (2003). Human Movement Sciences Faculty Publications. 78.
https://digitalcommons.odu.edu/hms_fac_pubs/78
Original Publication Citation
Colberg, S. R., Swain, D. P., & Vinik, A. I. (2003). Use of heart rate reserve and rating of perceived exertion to prescribe exercise
intensity in diabetic autonomic neueropathy. Diabetes Care, 26(4), 986-990. doi:10.2337/diacare.26.4.986
Use of Heart Rate Reserve and Rating of
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AARON I. VINIK, MD, PHD2
OBJECTIVE — Individuals with diabetic autonomic neuropathy (DAN) exhibit an increased
resting heart rate but depressed maximal heart rate. Thus, the purpose of this study was to
examine the validity of using either percent of heart rate reserve (HRR) or a rating of perceived
exertion (RPE) scale to prescribe exercise intensity in diabetic individuals both with and without
DAN.
RESEARCH DESIGN AND METHODS — The subjects consisted of 23 individuals
with type 2 diabetes, ages 45–75 years, with (DAN; n  13) or without (No DAN; n  10) clinical
signs of DAN, as assessed by heart rate variability using the expiration-to-inspiration ratio of the
R-R interval. Peak aerobic capacity was determined using a graded protocol on a cycle ergometer,
with RPE, heart rate, and VO2 values recorded at each stage.
RESULTS — The subjects were similar with the exception of depressed autonomic function in
DAN subjects. Peak respiratory exchange ratio values were significantly higher (P  0.05) in the
DAN group (1.08  0.02 vs. 1.02  0.01 in No DAN subjects), although DAN subjects exhibited
a significantly lower (P  0.05) peak exercise heart rate. A similarly highly linear relationship
between %HRR and percent VO2 reserve (VO2R) existed for both groups (r  0.98). A similar
slightly weaker relationship (r  0.94) was found between RPE and %VO2R.
CONCLUSIONS — In conclusion, in diabetic individuals, %HRR provides an accurate pre-
diction of %VO2R and can be used to prescribe and monitor exercise intensity, regardless of the
presence of DAN. The RPE scale is also a valid, albeit slightly less accurate, method to monitor
exercise intensity in diabetic individuals.
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Until recently, the linear relationshipbetween the percent of heart ratereserve (HRR) and percent of max-
imal aerobic capacity (VO2max) led to the
use of %HRR to quantify a given percent-
age of VO2max. Recent studies in healthy
adults, however, have shown that the two
were not equivalent—rather that %HRR
is equivalent or more closely related to the
percent VO2 reserve (VO2R) (i.e., a per-
centage of the difference between resting
and maximal VO2 at which an individual
is exercising) than to %VO2max (1,2).
These findings led the American College
of Sports Medicine to adopt %VO2R in
place of %VO2max for the prescription of
exercise intensity, which in normal indi-
viduals is now generally prescribed as a
percentage of maximal heart rate (60–
90%), VO2R (50 – 85%), or HRR (50 –
85%) (3,4). An alternate method of
prescribing intensity is with the rating of
perceived exertion (RPE) scale (5), which
uses a subjective rating from 6 to 20 to
quantify an individual’s perceived exer-
cise intensity.
Individuals with diabetic autonomic
neuropathy (DAN) do not have a normal
hemodynamic response to exercise. Auto-
nomic neuropathy interferes with normal
heart rate regulation during exercise by
depressing maximal heart rate and blood
pressure and at rest by increasing resting
heart rate (6,7). Such individuals exhibit a
lower peak heart rate response, lower
peak plasma epinephrine, and lower
plasma norepinephrine immediately after
exercise, indicative of an altered sympa-
thoadrenal response to physical activity
(8). In addition, maximal aerobic capacity
(VO2max) has been shown to be lesser in
some type 2 diabetic individuals both
with and without DAN (9–12).
Given the abnormal hemodynamic
responses seen in DAN, the American
College of Sports Medicine recommends
the use of the RPE scale in lieu of %HRR or
percentage of maximal heart rate for pre-
scribing exercise intensity in individuals
with DAN (13). However, neither the RPE
scale nor the use of HRR has been vali-
dated in the diabetic population. There-
fore, the purpose of the present study was
to examine the validity of using either
%HRR or RPE as the equivalent of %VO2R
to prescribe and monitor exercise inten-
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sity in a type 2 diabetic population both
with and without DAN.
RESEARCH DESIGN AND
METHODS — Subjects of both sexes
and all ethnicities were recruited using
the database of patients available at the
Strelitz Diabetes Research Institute and
locally distributed flyers and notices. The
testing and assessments for this project
took place at Old Dominion University
and Eastern Virginia Medical School,
both located in Norfolk, Virginia. The
subjects were individuals with type 2 di-
abetes, ages 45–75 years, divided into two
groups: those without DAN (No DAN;
n  10) and those with DAN (DAN; n 
13). Potential subjects with known car-
diovascular disease, severe peripheral
neuropathy, unstable proliferative reti-
nopathy, end-stage renal disease, or un-
controlled hypertension were excluded
from participation. During participation
in exercise testing, all subjects continued
to take their normal medications; two
DAN subjects were using -blockers that
lowered their resting and exercise heart
rates.
Heart rate variability with deep
breathing using the inspiration-to-
expiration ratio of the R-R interval (E:I
ratio) was used to evaluate systemic (va-
gal) autonomic function (14). To com-
plete this testing procedure, subjects were
asked to wear standard electrocardiogram
electrodes during deep breathing (six
breaths per minute). Heart rate variance
was recorded using an Anscore device
(Boston Medical Technologies, Wake-
field, MA) as the longest R-R interval (in
milliseconds) during expiration divided
by the shortest R-R interval during inspi-
ration. The average of six of these individ-
uals’ ratios was used as the final ratio.
Resting measures of heart rate and ox-
ygen uptake (VO2) were recorded after
each subject had sat quietly in a chair for
10 min to replicate a typical state of rest
that could be easily reproduced in a clin-
ical setting, as has been previously re-
ported (1,2). All subjects had fasted
overnight before testing and had ab-
stained from vigorous exercise for at least
24 h. Peak aerobic capacity (VO2peak) was
then determined using an incremental ex-
ercise protocol on a cycle ergometer
(Monark 828e). After familiarization with
the cycle ergometer, subjects were fitted
with a facemask and head strap. The test-
ing protocol began with subjects cycling
at 50 rpm at an external power of 0 W for
the first 3 min for females (20 W for
males), with 20-W increments occurring
every 3 min thereafter until test termina-
tion. An online open indirect calorimetry
system (K4b2Portable Metabolic System;
Cosmed, Rome, Italy) was used to mea-
sure and record VO2, expired minute ven-
tilation, and respiratory exchange ratio
(RER) at rest and during the exercise test.
Heart rate throughout the testing was
monitored using a Polar heart rate moni-
tor along with 12-lead electrocardiogram
recordings taken at each stage. Blood
samples were obtained at the end of each
stage via fingerstick, and blood was as-
sayed using a glucose and lactate analyzer
(YSI 2300; Yellow Springs Instruments,
Yellow Springs, OH). All tests were termi-
nated at the point of the subjects’ voli-
tional fatigue (indicated by hand gesture).
VO2peak was determined as the highest ox-
ygen uptake averaged over 30 s during the
final stage of exercise testing.
Only those tests in which the subject
achieved a plateau in oxygen consump-
tion and/or an RER of 1.0 were included
in the analyses; this minimum RER was
used to allow for the decreased maximal
exercise capacity that has been reported
in obese individuals with BMIs similar to
the subjects in the current study (15,16).
HRR and VO2R were calculated by sub-
tracting resting heart rate or VO2 values
from their respective peak values; accord-
ingly, for each stage of exercise, the incre-
ment above resting for each value was
divided by the calculated reserve and
multiplied by 100 to get %HRR or
%VO2R.
Statistical analyses were completed
using t tests (two-tailed) to compare dif-
ferences between group means and using
Pearson product-moment correlational
analysis to determine the relationship be-
tween %Vo2R and %HRR or RPE for each
subject. In addition, t tests were used to
determine whether the mean slope and
y-intercept for each group differed from
the line of identity (slope  1 and y-inter-
cept  0). The  level was set at P  0.05.
RESULTS — Resting characteristics of
the subjects before exercise are presented
in Table 1. Subjects in both groups were
similar in all respects with the exception
of E:I ratio, which was significantly de-
pressed in the DAN group. These values
were also significantly lower in compari-
son to age-dependent values in the nor-
mal population (17).
The subjects’ responses during peak
exercise are presented in Table 2. A trend
(P  0.11) for a lower VO2peak was evident
in the DAN subjects. Evidence of true
maximal effort was somewhat lacking in
many of the subjects in both groups be-
cause only 7 of 23 achieved a plateau in
VO2 (5 DAN and 2 No DAN subjects),
although others reported that a plateau is
not necessary for attainment of VO2max
(16). Peak RER was significantly higher
(P  0.05) in the DAN group than in the
No DAN group, although DAN subjects
exhibited a significantly lower (P  0.05)
peak exercise heart rate. Data from an
equivalent number of DAN and No DAN
subjects (four and five, respectively) were
excluded before analyses were performed
after subjects failed to meet the criteria of
attaining a plateau in VO2 and/or a peak
RER 1.0.
A highly linear relationship (r 
0.98) between %HRR and %VO2R was ev-
ident, as illustrated in Fig. 1. No signifi-
cant difference between the mean
regressions (slope and y-intercept) for
DAN and No DAN subjects was evident;
Table 1—Characteristics of resting subjects
DAN No DAN P
n (M/F) 13 (8/5) 10 (6/4) —
Age (years) 62.9  2.8 58.0  2.2 0.20
Height (cm) 170  2.9 173  3.7 0.49
Weight (kg) 88.3  5.8 94.8  4.0 0.39
BMI (kg/m2) 30.5  1.5 31.9  1.7 0.53
E:I ratio 1.05  0.01 1.24  0.04 0.001
Fasting glucose (mmol/l) 7.06  0.73 5.83  0.47 0.22
VO2 (ml  min
1  kg1) 2.9  0.4 2.9  0.4 0.89
Heart rate (bpm) 80  4 75  6 0.48
Data are means  SE unless otherwise indicated.
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thus, data from both subject groups were
combined. For all subjects, the mean
slope was 0.98  0.01, the mean y-
intercept was 2.6  1.7, and the mean
correlation coefficient was 0.98  0.01.
The slope and y-intercept were not signif-
icantly different from 1.0 and 0, respec-
tively (i.e., the regression line was not
different from the line of identity for
%HRR and %VO2R).
Figure 2 shows the highly linear rela-
tionship (r  0.94) between RPE and
%VO2R. Data from both subject groups
were again combined because no signifi-
cant difference between the mean regres-
sions for DAN and No DAN subjects was
detectable. For all subjects, the mean
slope was 0.11  0.01, the mean inter-
cept was 5.3  0.2, and the mean corre-
lation coefficient was 0.94  0.02.
Assuming that a value of 6 on the RPE
scale represents rest and 20 represents
maximal effort, the expected regression
line would have a slope of 0.14 and an
intercept of 6.0. However, the mean slope
and mean intercept were both signifi-
cantly different (P  0.001) than these
values, as shown in Fig. 2.
If the relationships between either
%HRR or RPE and %VO2R are to be used
in exercise prescription, it would be use-
ful to reverse the dependent and indepen-
dent variables so that the %HRR or RPE
can predict the desired %VO2R. Doing so
with all subject data grouped together (to
allow the calculation of a standard error of
the estimate [SEE]) provides the follow-
ing regression equations: %VO2R  0.95
(%HRR)  6.8, with r  0.95 and SEE 
10.6%VO2R units, and %VO2R  7.14
(RPE)  25.1, with r  0.87 and SEE 
16.9%VO2R units. The SE for each indi-
vidual subject was significantly smaller
than the SEE for the group.
CONCLUSIONS — This study ex-
amined the relationship between VO2R
and HRR in diabetic individuals with and
without clinical DAN. We have demon-
strated that %HRR is an excellent indica-
tor of %VO2R in individuals with diabetes,
regardless of the presence of autonomic
neuropathy. This finding is consistent
with findings for healthy adults (1,2) and
cardiac patients (18). Furthermore, a sig-
nificant, but less strong, relationship
between RPE and %VO2R was also dem-
onstrated in both groups of diabetic sub-
jects.
Previous exercise recommendations
have been based on the assumption that
DAN would interfere with the heart rate
response to exercise to such a degree as to
reduce the utility of heart rate or HRR as
methods for prescribing exercise inten-
sity. To the contrary, in the present study,
we demonstrated that although peak
heart rate was depressed in subjects with
DAN, as has been found previously (6,7),
a linear relationship between %HRR and
%VO2R was nevertheless retained and that
this relationship was indistinguishable
from the line of identity. Our findings are
similar to those of Brawner et al. (18) in
cardiac patients; they found that the
%HRR versus %VO2R relationship was
consistent with the line of identity for car-
diac patients with or without -adrener-
gic blockade therapy. In our subjects,
however, as in cases of -blockade use, it
is important to accurately determine each
subject’s resting and peak or maximal
heart rates rather than using estimates
(maximal values are usually estimated in a
normal population as 220  age or 208 
70% of age); the maximal value may be
overestimated and resting heart rate under-
estimated due to the effects of DAN on
these heart rate measures.
An alternative method for prescribing
exercise intensity in a diabetic popula-
tion, the RPE scale, is a subjective tool that
may be used in place of heart rate, and its
use has been the recommendation for pa-
tients with DAN (13). In normal popula-
tions, use of the RPE scale has been
validated for level treadmill running (19)
and during incremental exercise on a cy-
cle ergometer (20,21). The current study
found a highly linear relationship be-
tween RPE and %VO2R, providing sup-
port for its continued use by diabetic
individuals. However, we found that the
SEE for this relationship was not as good
as the SEE for %HRR versus %VO2R.
Moreover, the RPE values recorded in this
study were lower than expected, most
likely because some subjects may not
have attained true maximal efforts.
Admittedly, it can be difficult to elicit
true maximal efforts from patient popula-
tions, especially DAN patients who may
be limited by symptoms. In diabetic indi-
viduals with DAN who are otherwise
asymptomatic, DAN is a good predictor of
major cardiac events (22) and the risk for
cardiac-cerebrovascular events is high
(8,22). Such individuals exhibit an abnor-
mal left ventricular response to isometric
and dynamic exercise that is due to a de-
Figure 1—Relationship between %HRR and %VO2R in DAN () and No DAN (f) subjects with
mean regression line [%HRR  0.98 (%VO2R)  2.6; mean r  0.98] and line of identity.
Table 2—Subjects’ responses to peak cycle ergometer exercise
DAN No DAN P
VO2 (ml  min
1  kg1) 15.1  1.3 19.0  2.1 0.11
RPE 17.1  0.7 16.7  0.8 0.73
RER 1.08  0.02 1.02  0.01 0.04
Heart rate (bpm) 131  4 146  6 0.04
Lactate (mmol/l) 3.8  0.3 4.1  0.4 0.52
Data are means  SE.
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fective inotropic recruitment, despite the
presence of a normal left ventricular con-
tractile reserve (23). Furthermore, as
noted previously, obese subjects such as
the ones in this study have often been re-
ported to attain lower heart rates and RER
values during maximal efforts (15,16).
In recognition of these potential risks
and limitations of the subject population,
the criteria for maximal effort in the
present study were established as the at-
tainment of a plateau in oxygen consump-
tion or an RER value of at least 1.0. A
value of 1.10 is often used in studies with
nonpatient groups (1,2), but only six of
our subjects actually reached that stan-
dard; seven subjects attained a plateau in
VO2, whereas three other subjects attained
both a plateau in VO2 and an RER of at
least 1.10. In addition, the use of a cycle
ergometer rather than a treadmill resulted
in VO2peak rather than VO2max. Thus, one
possible interpretation of our data is that
the RPE values reported in this study are
low simply because many of the subjects
decided to stop their incremental exercise
tests before reaching a true maximum ef-
fort. Doing so, however, would not affect
the %HRR-%VO2R relationship because
that regression used peak values for both
variables as the end points of the regres-
sion.
Another potential complication exists
with regard to the interpretation of our
RPE data. Some of the subjectivity in-
volved in determining an RPE rating for a
given exercise workload depends on the
normal functioning of the sympathetic
nervous system (e.g., lactate accumula-
tion from muscle glycogen release or
sweating responses). Individuals with
DAN may not experience some of these
usual symptoms associated with work-
loads of increasing intensity. In another
study involving incremental exercise by
individuals with diabetes on a cycle er-
gometer, heart rate, systolic blood pres-
sure, norepinephrine, and epinephrine
increases were most severely blunted in
individuals with both parasympathetic
and sympathetic damage to the auto-
nomic nervous system (10). In our study,
however, only parasympathetic DAN was
assessed with the use of the E:I ratio, and
peak lactate was similar in both diabetic
groups, suggesting that the utility of our
RPE measurements was not compro-
mised.
In conclusion, we have demonstrated
that in diabetic individuals, %HRR pro-
vides an accurate prediction of %VO2R
and can be used for this population to
prescribe and monitor exercise intensity,
regardless of the presence of DAN; as
such, it should preferably be the method
used. As an alternate, albeit slightly less
accurate, method, RPE can be used to
monitor exercise intensity in diabetic in-
dividuals and may be useful in clinical
settings where maximal or peak heart rate
is not easily measured and %HRR is there-
fore not routinely used.
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